OTC “Time & Extent” Requirements Reduced For Extensively Marketed Drugs
This article was originally published in The Rose Sheet
Executive Summary
Sponsors of OTC drugs with extensive foreign marketing experience need not provide detailed information from each country in requesting the drug or "condition" be considered for OTC monograph eligibility in the U.S., FDA says
You may also be interested in...
FDA Will Consider Triclosan For OTC Acne Monograph Inclusion
FDA is seeking data on use of triclosan in topical acne treatment products, the agency announced in a Dec. 5 Federal Register 1notice
FDA Will Consider Triclosan For OTC Acne Monograph Inclusion
FDA is seeking data on use of triclosan in topical acne treatment products, the agency announced in a Dec. 5 Federal Register 1notice
FDA Draft Guidance Clarifies OTC Time & Extent Applications
Time & extent applications for OTC monograph eligibility should describe adverse event reporting systems in countries outside the U.S. where active ingredients have been marketed, according to an FDA draft guidance